Arcus Biosciences
RCUS
RCUS
206 hedge funds and large institutions have $2.89B invested in Arcus Biosciences in 2025 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 95 increasing their positions, 38 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
70% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 27
17.92% more ownership
Funds ownership: 94.53% → 112.46% (+18%)
9% more funds holding
Funds holding: 189 → 206 (+17)
Holders
206
Holding in Top 10
4
Calls
$92.8M
Puts
$5.26M
Top Buyers
| 1 | +$79.9M | |
| 2 | +$69.1M | |
| 3 | +$65M | |
| 4 |
SC
Samlyn Capital
New York
|
+$32.7M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$30.6M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$21.5M | |
| 3 | -$15.5M | |
| 4 |
Millennium Management
New York
|
-$9.51M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$7.34M |
